Search
Now showing items 1-2 of 2
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
Ettrich, Thomas J. et al. (2018)
Wissenschaftlicher Artikel
PKD regulates actin polymerization, neutrophil deformability, and transendothelial migration in response to fMLP and trauma
Wille, Christoph et al. (2018)
Wissenschaftlicher Artikel